Unusual Machines, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
UMAC$12.59-6.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Consolidated Condensed Statements of Cash Flows
Consolidated Condensed Statement of Cash Flows
For the Nine Months Ended September 30, 2025 and 2024
| Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net loss | $(8,627,553) | $(4,862,490) |
| Depreciation and amortization | 63,635 | 513 |
| Stock compensation expense as settlement | – | 64,344 |
| Stock compensation expense | 9,522,261 | 759,673 |
| Unrealized gains from short term investments | (5,849,713) | – |
| Bad debt | 12,146 | – |
| Change in fair value for warrant and derivative liabilities | – | (43,239) |
| Loss on debt extinguishment, non-cash component | – | 663,250 |
| Change in assets: | ||
| Accounts receivable | (122,696) | (73,109) |
| Inventory | (1,746,100) | 337,562 |
| Prepaid inventory | (6,016,951) | (319,532) |
| Other assets | (165,529) | (29,100) |
| Operating lease right-of-use asset | 72,202 | – |
| Change in liabilities: | ||
| Accounts payable and accrued expenses | 406,399 | 630,595 |
| Operating lease liabilities | (80,346) | (33,056) |
| Customer deposits and other current liabilities | 1,137,953 | 186,076 |
| Net cash used in operating activities | (11,394,294) | (2,718,513) |
| Cash flows from investing activities | ||
| Cash portion of consideration paid for acquisition of businesses, net of cash received | 93,054 | (852,801) |
| Investments in short term securities | (11,000,000) | – |
| Purchases of property and equipment | (1,550,687) | – |
| Net cash used in investing activities | (12,457,633) | (852,801) |
| Cash flows from financing activities: | ||
| Proceeds from issuance of common shares, IPO | – | 5,000,000 |
| Proceeds from issuance of common shares, public offering | 40,000,000 | – |
| Proceeds from issuance of common shares, registered direct | 48,500,000 | – |
| Proceeds from option exercises | 501,610 | – |
| Proceeds from issuance of common shares, warrant exercises | 2,479,466 | – |
| Common share issuance offering costs | (7,103,000) | (637,687) |
| Net cash provided by financing activities | 84,378,076 | 4,362,313 |
| Net increase in cash | 60,526,149 | 790,999 |
| Effect of exchange rate changes on cash | 2,278 | – |
| Cash, beginning of period | 3,757,323 | 894,773 |
| Cash, end of period | $64,285,750 | $1,685,772 |
| Supplemental disclosures of cash flow information: | ||
| Non-cash consideration paid for assets acquired and liabilities assumed | $8,922,911 | $19,000,000 |
| Non-cash right of use asset and liability | $973,443 | $– |
| Deferred acquisition costs | $– | $100,000 |
| Deferred offering costs recorded as reduction of proceeds | $– | $512,758 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.